omniture
Choi Youn Woong

Latest News

World-Renowned Scientist Wah Chiu, Stanford University Professor and Honorary Advisor to Pohang City, visited Korea at the invitation of the Coree Group

- Seminar presentation at the invitation of Dx&Vx and Coree Group SEOUL, South Korea, Aug. 26, 2024...

2024-08-26 21:00 1929

DX&VX is on Track and Accelerating the Development of Oral Obesity Treatment

* Confirmation of effects compared to global late-stage clinical trials * Accelerating the devel...

2024-07-18 21:00 2382

Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success

* To be registered as an official research organization by the National Assembly Secretariat... ...

2024-04-19 21:00 2916

Mr. Chong-Yoon Lim, Chairman of COREE Group emphasizes "Creative destruction and Healthcare 4.0" [New Year Message at X-Twitter SNS]

SEOUL, South Korea, Jan. 3, 2024 /PRNewswire/ -- Chong-Yoon Lim, Chairman of COREE group, President...

2024-01-03 22:00 2283

Dx&Vx co-develops a bio-healthcare big data platform with LG CNS

- Possessing human genome and microbiome data in all clinical stages - Becoming a global bio-healthc...

2023-12-20 22:00 2237

DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia

- Final stage in licensing OVM-200 from Oxford Vacmedix in the UK - DxVx plans to proceed its own cl...

2023-11-24 22:00 3630

DxVx, won the governmental project to develop diagnostic sensor kit for adult diseases

* National Project converging semiconductor and biotechnology SEOUL, South Korea, June 9, 2023 /P...

2023-06-09 21:00 4850

Avixgen accelerates the progress on new drug pipeline development

- Pipeline development updates on age related macular degeneration, dry eye disease and atopic derm...

2023-05-24 21:00 2928

DxVx appoints Yong Gu Lee as new CEO and Kevin Kwon as the new president

- Reorganizing the global sales networks and enhancing its capabilities to get global approvals for...

2023-05-16 21:00 2849

DxVx Co., Ltd.'s affiliated company, Oxford Vacmedix (OVM) successfully completed Phase 1a in clinical trial of novel cancer vaccine OVM-200

SEOUL, South Korea, March 30, 2023 /PRNewswire/ -- DXVX announces that its affiliated company Oxfor...

2023-03-30 17:39 1890

Research Collaboration between Prof. Antonio Gasbarrini team at Gemelli Hospital and Asian Biotech companies, Coree and Dx&Vx

SEOUL, South Korea, Oct. 13, 2022 /PRNewswire/ -- According to International Diabetes Federation, a...

2022-10-13 21:00 1338